Posted in | News | Biomaterials

Analytical Toolkit For Biopharmaceutical Applications Discussed By Malvern

A recent Malvern Panalytical sponsored webinar, presented by specialists from the company, examined the need for specific analytical tools for biopharmaceutical applications. The recording of the live event, which attracted more than 600 registrants, is now available to view online at http://bit.ly/MALOTACB

 

 

In the presentation, Mark Pothecary and Paul Clarke, Product Manager and Product Group Manager respectively for Nanoparticle and Molecular Characterization at Malvern Panalytical, discuss a variety of the analytical technologies that are available for the growing biopharmaceutical industry. They provide fresh insights into the use of a number of well-established characterization techniques, including light scattering and size exclusion chromatography (GPC/SEC) and illustrate the use of these techniques in combination, showing how they can provide a wide range of complementary information useful to protein scientists.

The continued shift within the industry towards biopharmaceuticals has resulted in the need for analytical instrumentation that can quickly deliver compelling solutions to meet rapidly evolving analytical and regulatory challenges. In particular the move towards drugs using biomolecules as the active has stimulated advances in new analytical procedures. As well as traditional techniques, such as GPC/SEC and dynamic light scattering (DLS), which can be performed separately or in combination (SEC-DLS), new technologies including microrheology and resonant mass measurement are rapidly becoming essential components of the analytical toolkit.

Within Malvern Panalytical, the company’s global Bioscience Development Initiative recognizes the unprecedented pace of development in biopharmaceuticals and the onus this places on analytical instrumentation companies to quickly deliver solutions to a host of rapidly evolving analytical and regulatory challenges. Malvern Panalytical’s Bioscience Development Initiative is focused specifically on the requirements of the biopharmaceutical sector, most notably the biochemical and biophysical characterization needs relating to formulation and product development.

To access the webinar go to: http://bit.ly/MALOTACB

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2021, March 09). Analytical Toolkit For Biopharmaceutical Applications Discussed By Malvern. AZoM. Retrieved on February 29, 2024 from https://www.azom.com/news.aspx?newsID=36357.

  • MLA

    Malvern Panalytical. "Analytical Toolkit For Biopharmaceutical Applications Discussed By Malvern". AZoM. 29 February 2024. <https://www.azom.com/news.aspx?newsID=36357>.

  • Chicago

    Malvern Panalytical. "Analytical Toolkit For Biopharmaceutical Applications Discussed By Malvern". AZoM. https://www.azom.com/news.aspx?newsID=36357. (accessed February 29, 2024).

  • Harvard

    Malvern Panalytical. 2021. Analytical Toolkit For Biopharmaceutical Applications Discussed By Malvern. AZoM, viewed 29 February 2024, https://www.azom.com/news.aspx?newsID=36357.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.